Articles Referencing RMD
ResMed Inc. (RMD) Ex-Dividend Date Scheduled for May 17, 2013
5/16/2013, 9:00 am from NASDAQ.com News in News Headlines, Stocks
ResMed Inc. ( RMD
) will begin trading ex-dividend on May 17, 2013. A cash dividend
payment of $0.17 per share is scheduled to be paid on June 18,
2013. Shareholders who purchased RMD stock... Read >>
X Factor: 5 Stocks Reaching Their Ex-Dividend Date on May 17
5/10/2013, 9:02 am from Minyanville in Investing, Stocks
Twelve stocks will reach their ex-dividend date next Friday,
which is significant for investors as the seller of the stock on
that date, not the buyer, receives the most recent dividend.
A ... Read >>
Got Growth?
5/2/2013, 1:00 pm from Validea in Investing, Stocks
With first-quarter U.S. GDP growth falling short of expectations
and few expecting much in the way of broader economic growth for
the rest of the year, investors are once again considering... Read >>
ResMed's Earnings Beat; Revs Lag - Analyst Blog
4/29/2013, 2:50 pm from Zacks.com in Investing, Business, Earnings, Stocks
ResMed Inc. (RMD) posted adjusted earnings per share (EPS) of 59
cents in the third quarter of fiscal 2013, edging past the Zacks
Consensus Estimate by a couple of cents. The results were... Read >>
ResMed Eyes Continued Growth Despite Medicare Cuts
4/18/2013, 4:07 pm from Investor's Business Daily in Investing, Investing Ideas
It's fitting that ResMed specializes in equipment to treat
sleep disorders, because the company has had to convince
investors not to lose sleep over the potential impact of Medicare
... Read >>
ResMed Protects Patent Landscape - Analyst Blog
4/2/2013, 2:18 pm from Zacks.com in Investing, Business, Stocks
Recently, ResMed ( RMD ) filed parallel
lawsuits in the International Trade Commission (ITC) and U.S.
federal court to protect its patent landscape from its
international competitor APEX... Read >>
Another Study for STJ's EnligHTN - Analyst Blog
2/22/2013, 3:00 pm from Zacks.com in Investing, Business, Stocks
St. Jude Medical Inc. ( STJ ) has initiated a
multi-center, randomized controlled study to analyze the
effectiveness of its EnligHTN Renal Denervation System in reducing
major... Read >>
Safeway Ticks Higher on 4Q Results - Analyst Blog
2/22/2013, 2:40 pm from Zacks.com in Investing, Business, Stocks
Shares of Safeway ( SWY ) touched a new
52-week high of $23.96 on Thursday, Feb 21, 2013, following the
release of the fourth-quarter results. The 17.6% surge in company's
profit boosted... Read >>
Symmetry Misses but Up Y-Y - Analyst Blog
2/22/2013, 12:50 pm from Zacks.com in Investing, Business, Stocks
Symmetry Medical Inc. 's ( SMA ) fourth-quarter
2012 adjusted earnings of 15 cents a share missed the Zacks
Consensus Estimate of 19 cents. Adjusted earnings exclude one-time
items other... Read >>
Align Upgraded to Neutral - Analyst Blog
2/20/2013, 3:00 pm from Zacks.com in Investing, Business, Stocks
We recently upgraded Align Technology ( ALGN ) to Neutral
based on its encouraging fourth-quarter 2012 results and huge
opportunities in the malocclusion market. Banking on its core
product... Read >>
BioScrip Reaffirmed at Neutral - Analyst Blog
2/20/2013, 2:50 pm from Zacks.com in Investing, Business, Stocks
We maintain our long-term Neutral recommendation on BioScrip
Inc. (BIOS). Although the company has several positive catalysts to
drive growth over the long haul, looming concerns keep us on... Read >>
Qiagen in Collaboration with Lilly - Analyst Blog
2/15/2013, 2:20 pm from Zacks.com in Investing, Business, Stocks
In an attempt to expand its companion diagnostics portfolio,
Qiagen N.V. ( QGEN ) entered into a
new co-development agreement with global pharmaceutical product
manufacturers Eli Lilly... Read >>
Zimmer Stays at Neutral - Analyst Blog
2/15/2013, 1:30 pm from Zacks.com in Investing, Business, Stocks
We recently reiterated our Neutral recommendation on
Zimmer Holdings ( ZMH ), a leading
orthopedic medical devices company. While we hold a favorable view
regarding the company's gradually... Read >>
Thermo Fisher Remains at Neutral - Analyst Blog
2/13/2013, 5:44 pm from Zacks.com in Investing, Business, Stocks
We recently reiterated our Neutral recommendation on
Thermo Fisher Scientific ( TMO ), a major
scientific instrument maker. While we hold a favorable view
regarding the company's huge... Read >>
CVS Broadens Pharmacy Advisor - Analyst Blog
2/13/2013, 5:25 pm from Zacks.com in Investing, Business, Stocks
CVS Caremark ( CVS ) recently extended
its innovative Pharmacy Advisor program to cover five additional
chronic conditions, namely asthma, depression, osteoporosis, breast
cancer and... Read >>